Surgery for epilepsy leads to around half of patients being seizure-free after 10 years
Around half of patients remain seizure free 10 years after undergoing surgery for epilepsy. However, there is scope for further improvement in presurgical assessment and surgical treatment of people with chronic epilepsy. The findings are reported in an Article published in this week's surgery special issue of The Lancet, written by Jane de Tisi, Dr Gail S Bel, and Professor John Duncan, National Hospital for Neurosurgery, and Imperial College London, and colleagues.
In this new work, the authors identified long-term outcome of epilepsy surgery in adults by establishing patterns of seizure remission and relapse after surgery. Long-term outcome of surgery for epilepsy in 615 adults was analysed (497 anterior temporal resections, 40 temporal lesionectomies, 40 extratemporal lesionectomies, 20 extratemporal resections, 11 hemispherectomies, and seven palliative procedures [corpus callosotomy, subpial transection]), with a median annual follow-up of 8 years.
The authors estimated that 52% of patients remained seizure free (apart from simple partial seizures [SPS]) at 5 years after surgery, and 47% at 10 years. Patients who had extratemporal resections were twice as likely to have seizure recurrence than were those who had anterior temporal resections. For those having temporal lesionectomies, no difference from anterior temporal lobe resection was recorded. Those with SPS in the first 2 years after temporal lobe surgery had a two-and-a-half times greater chance of subsequent seizures with impaired awareness than did those with no SPS. Relapse was less likely the longer a person was seizure free and, conversely, remission was less likely the longer seizures continued. In 18 (19%) of 93 people, late remission was associated with introduction of a previously untried antiepileptic drug. 104 of 365 (28%) seizure-free individuals had discontinued drugs at latest follow-up.
Drilling deeper into the data, the authors reveal that 40% of patients have long-term complete seizure freedom after epilepsy surgery, with a further 11% having only SPS. Although 82% had at least 1 year with no seizures or only SPS, this does not indicate cure. No patient had substantial worsening of epilepsy. The authors say that clinical practice should change to sooner refer appropriate patients for possible surgery. At the moment, best practice is to consider surgery for focal epilepsy only if drugs have not been effective for controlling seizures for over 2-3 years. Selection process and surgical methods need improvement to increase success rates and to more accurately identify those who will not benefit from surgery. Some previous studies could, say the authors, have implied overoptimistic expectations.
The fact that SPS continuing in the first 2 years after surgery increases the chances of seizures recurring compared with those entirely seizure free is a new finding has not been previously reported. Such important information might affect the decision to taper or continue antiepileptic drugs. Interestingly, most people who are seizure free after surgery choose to remain on an antiepileptic drug. No prospective randomised trial is available of cessation or continuation of antiepileptic drugs after surgery, and consideration of either pregnancy or obtaining a driving licence seem to be major factors in an individual's decision making. Elaborating, the authors explain that taking antiepileptic drugs is not a bar to driving. The key is to be free of seizures for 12 months, and to remain seizure free. Taking a single antiepileptic drug through pregnancy carries a 2-3% risk of major congenital malformation, so if a female is seizure free following surgery and is contemplating pregnancy, she may well consider seriously stopping medication prior to conception.
The authors conclude: "For seizure outcome, surgery is successful for many individuals in whom antiepileptic drugs have not been effective, but further improvements need to be made to presurgical assessment to further increase rates of success."
In a linked Comment, Dr Ahmed-Ramadan Sadek, and Professor William Peter Gray, Wessex Neurological Centre, Southampton University Hospitals NHS Trust and University of Southampton, UK, say the new data will be useful for counseling epilepsy patients and guiding their physicians. They conclude: "This study validates the long-term effectiveness of epilepsy surgery showing that over 50% of all patients are rendered continuously long-term seizure free; it also raises important questions and challenges. Are the benefits of seizure freedom apportioned equally to the continuous and later remission groups? Can selection and reselection strategies be further improved to optimise long-term seizure control? Finally, the median duration of epilepsy before surgery in this study was 20 years. In view of the long-term results of surgery shown, clinical practice needs to change with the early referral of appropriate patients."
More information: Paper online: www.thelancet.com/… 0-8/abstract
Provided by Lancet
- Analysis supports use of surgery to treat medication-resistant epilepsy Dec 02, 2008 | not rated yet | 0
- Treatment-resistant epilepsy common in idiopathic autism Apr 19, 2011 | not rated yet | 0
- Study finds it generally safe to withdraw anti-seizure medication in children with epilepsy Dec 07, 2008 | not rated yet | 0
- Fast ripples confirmed to be valuable biomarker of area responsible for seizure activity in children Jul 29, 2011 | not rated yet | 0
- Surgery safe for babies and toddlers suffering from seizures Mar 23, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
A new coronavirus has now claimed 22 lives worldwide out of 44 lab-confirmed cases, mostly in Saudi Arabia, World Health Organization officials said Thursday.
Diseases, Conditions, Syndromes 2 hours ago | not rated yet | 0
A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...
Diseases, Conditions, Syndromes 3 hours ago | not rated yet | 0 |
As the world prepares for what may be the next pandemic strain of influenza virus, in the H7N9 bird flu, a new UC Irvine study reveals that the 2009 H1N1 swine flu pandemic was deadliest for people under the age of 65, while ...
Diseases, Conditions, Syndromes 21 hours ago | not rated yet | 0
The World Health Organization says the Horn of Africa is experiencing an outbreak of polio with cases confirmed in Kenya and Somalia.
Diseases, Conditions, Syndromes 22 hours ago | not rated yet | 0
A man who had contracted the coronavirus has died in Saudi Arabia, raising the death toll in the kingdom from the SARS-like virus to 17, the health ministry announced on its website on Wednesday.
Diseases, Conditions, Syndromes 22 hours ago | not rated yet | 0
Little is known about why asthma develops, how it constricts the airway or why response to treatments varies between patients. Now, a team of researchers at Weill Cornell Medical College, Columbia University Medical Center ...
58 minutes ago | not rated yet | 0 |
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of ...
33 minutes ago | 5 / 5 (1) | 0 |
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
32 minutes ago | not rated yet | 0 |
(Medical Xpress)—The human brain is able to identify individuals' voices by comparing them against an internal 'average voice' prototype, according to neuroscientists.
49 minutes ago | not rated yet | 0 |
An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science.
26 minutes ago | not rated yet | 0 |
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
33 minutes ago | not rated yet | 0 |